Log in Register
Menu

Anti-HLA-A2 [BB7.2]

Invented by Prof Walter Bodmer at University of Oxford

Info

Catalogue Number 151297
Applications FACS IHC IF Fn
Antigen/Gene or Protein Targets Human Leukocyte Antigen- A2
Reactivity Human
Relevance Human Leukocyte Antigens (HLA) are highly polymorphic proteins that are involved in the presentation of antigens to the T-cell receptor. There are two classes of HLA antigens, class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). This antibody can be used for HLA typing.
Host Mouse
Immunogen Papain solubilised HLA-A2,
Subclass IgG2b
Myeloma Used P3/NS1/1-Ag4.1
Recommended Growing Conditions DMEM + 5% FCS
Strain Balb/c
Notes BB7.2 fixes complement and is cytotoxic for peripheral blood leukocytes and lymphoid cell lines.

Chawla et al., 2016 - BB7.2 blocked the HLAA2/T cell receptor interactions and specifically killied target cells by E75-CTL.
Research Area Immunology

References: 22 entries

Huang et al. 2016 Scientific Reports.

FACS

Gunasekaran et al. 2016. Am J Transplant. :. PMID: 27278097.

Reches et al. 2016. J Immunol. :. PMID: 27194785.

FACS

Chawla et al. 2016. Cancer Immunol Immunother. :. PMID: 27129972.

Fn

Srivastava et al. 2016. J Virol. 90(8):3913-28. PMID: 26842468.

Nayak et al. 2016. Am J Transplant. :. PMID: 27062199.

MacDonald et al. 2016. J Clin Invest. 126(4):1413-24. PMID: 26999600.

Lasso et al. 2016. PLoS One. 11(3):e0150996. PMID: 26974162.

FACS

Lasso et al. 2016. Peptides. 78:68-76. PMID: 26854383.

Srivastava et al. 2016. J Virol. :. PMID: 26842468.

FACS

Ma et al. 2016. J Immunol. :. PMID: 26792804.

FACS

Mahiti et al. 2016. MBio. 7(1):. PMID: 26787826.

FACS

Horiuchi et al. 2015. Oncol Rep. :. PMID: 26398429.

IHC IF

Dellgren et al. 2015. PLoS One. 10(8):e0135385. PMID: 26258424.

Rancan et al. 2015. PLoS Pathog. 11(6):e1004906. PMID: 26067064.

FACS

Egui et al. 2015. PLoS One. 10(3):e0122115. PMID: 25816096.

Khan et al. 2015. J Virol. :. PMID: 25878105.

Noy et al. 2015. Mol Cancer Ther. :. PMID: 25852061.

Cheent et al. 2013. Proc Natl Acad Sci U S A. 110(42):16981-6. PMID: 24082146.

Whitfield-Larry et al. 2011. Diabetes. 60(6):1726-33. PMID: 21521873.

Parham et al. 1981. Hum Immunol. 3(4):277-99. PMID: 7035415.

Brodsky et al. 1979. Immunol Rev. 47:3-61. PMID: 95015.


Add a reference

References: 22 entries

Huang et al. 2016 Scientific Reports.

FACS

Gunasekaran et al. 2016. Am J Transplant. :. PMID: 27278097.

Reches et al. 2016. J Immunol. :. PMID: 27194785.

FACS

Chawla et al. 2016. Cancer Immunol Immunother. :. PMID: 27129972.

Fn

Srivastava et al. 2016. J Virol. 90(8):3913-28. PMID: 26842468.

Nayak et al. 2016. Am J Transplant. :. PMID: 27062199.

MacDonald et al. 2016. J Clin Invest. 126(4):1413-24. PMID: 26999600.

Lasso et al. 2016. PLoS One. 11(3):e0150996. PMID: 26974162.

FACS

Lasso et al. 2016. Peptides. 78:68-76. PMID: 26854383.

Srivastava et al. 2016. J Virol. :. PMID: 26842468.

FACS

Ma et al. 2016. J Immunol. :. PMID: 26792804.

FACS

Mahiti et al. 2016. MBio. 7(1):. PMID: 26787826.

FACS

Horiuchi et al. 2015. Oncol Rep. :. PMID: 26398429.

IHC IF

Dellgren et al. 2015. PLoS One. 10(8):e0135385. PMID: 26258424.

Rancan et al. 2015. PLoS Pathog. 11(6):e1004906. PMID: 26067064.

FACS

Egui et al. 2015. PLoS One. 10(3):e0122115. PMID: 25816096.

Khan et al. 2015. J Virol. :. PMID: 25878105.

Noy et al. 2015. Mol Cancer Ther. :. PMID: 25852061.

Cheent et al. 2013. Proc Natl Acad Sci U S A. 110(42):16981-6. PMID: 24082146.

Whitfield-Larry et al. 2011. Diabetes. 60(6):1726-33. PMID: 21521873.

Parham et al. 1981. Hum Immunol. 3(4):277-99. PMID: 7035415.

Brodsky et al. 1979. Immunol Rev. 47:3-61. PMID: 95015.


Add a reference

References: 22 entries

Huang et al. 2016 Scientific Reports.

FACS

Gunasekaran et al. 2016. Am J Transplant. :. PMID: 27278097.

Reches et al. 2016. J Immunol. :. PMID: 27194785.

FACS

Chawla et al. 2016. Cancer Immunol Immunother. :. PMID: 27129972.

Fn

Srivastava et al. 2016. J Virol. 90(8):3913-28. PMID: 26842468.

Nayak et al. 2016. Am J Transplant. :. PMID: 27062199.

MacDonald et al. 2016. J Clin Invest. 126(4):1413-24. PMID: 26999600.

Lasso et al. 2016. PLoS One. 11(3):e0150996. PMID: 26974162.

FACS

Lasso et al. 2016. Peptides. 78:68-76. PMID: 26854383.

Srivastava et al. 2016. J Virol. :. PMID: 26842468.

FACS

Ma et al. 2016. J Immunol. :. PMID: 26792804.

FACS

Mahiti et al. 2016. MBio. 7(1):. PMID: 26787826.

FACS

Horiuchi et al. 2015. Oncol Rep. :. PMID: 26398429.

IHC IF

Dellgren et al. 2015. PLoS One. 10(8):e0135385. PMID: 26258424.

Rancan et al. 2015. PLoS Pathog. 11(6):e1004906. PMID: 26067064.

FACS

Egui et al. 2015. PLoS One. 10(3):e0122115. PMID: 25816096.

Khan et al. 2015. J Virol. :. PMID: 25878105.

Noy et al. 2015. Mol Cancer Ther. :. PMID: 25852061.

Cheent et al. 2013. Proc Natl Acad Sci U S A. 110(42):16981-6. PMID: 24082146.

Whitfield-Larry et al. 2011. Diabetes. 60(6):1726-33. PMID: 21521873.

Parham et al. 1981. Hum Immunol. 3(4):277-99. PMID: 7035415.

Brodsky et al. 1979. Immunol Rev. 47:3-61. PMID: 95015.


Add a reference


This reagent does not have any reviews at the moment.